Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Mar 4, 2002

Premium

Peter Chambre, former COO at Celera Genomics, will join London-based Cambridge Antibody Technology as CEO in early April. He will succeed CAT founder and CEO David Chiswell.

 

The board of directors of Paradigm Genetics has fired John Ryals, a co-founder of the company and its CEO and president. Paradigm of Research Triangle Park, NC, did not offer a reason for Ryals’ dismissal, but a company spokeswoman told BioInform’s sister publication GenomeWeb that there had been “some dysfunction in the relationship between him and the board and him and the management team.” CSO John Hamer will assume Ryals’ duties while the company searches for a replacement.

Filed under

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.